Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 08-2021 | |
| Operating Expenses | 11,404 | 10,108 | 9,930 | 10,287 | 7,441 |
| Operating Income | -11,404 | -10,108 | -9,930 | -10,287 | -7,441 |
| Interest Expense | 277 | 0 | 0 | 5 | 0 |
| Other Income | -1,198 | 282 | 641 | 209 | 4 |
| Pre-tax Income | -12,879 | -9,826 | -9,289 | -10,083 | -7,437 |
| Net Income Continuous | -12,879 | -9,826 | -9,289 | -10,083 | -7,437 |
| Net Income | $-12,879 | $-9,826 | $-9,289 | $-10,083 | $-7,437 |
| EPS Basic Total Ops | -37.56 | -54.91 | -56.51 | -64.07 | -107.45 |
| EPS Basic Continuous Ops | -37.55 | -54.90 | -56.48 | -64.06 | -107.51 |
| EPS Diluted Total Ops | -37.56 | -54.91 | -56.51 | -64.07 | -107.45 |
| EPS Diluted Continuous Ops | -37.55 | -54.90 | -56.48 | -64.06 | -107.51 |
| EPS Diluted Before Non-Recurring Items | -37.56 | -54.89 | -56.51 | -64.07 | N/A |
| EBITDA(a) | $-11,196 | $-10,108 | $-9,930 | $-10,287 | $-7,441 |